Viridian Therapeutics, Inc. company logo
Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc. (VRDN) Cash From Investing

Annual CFI

-$228.65M$134.40M-142.60%

Summary

Current Value
As of today, VRDN annual cash from investing is -$228.65M, down -142.60% on
Historical Performance
VRDN annual cash from investing is down -207.77% over the past 3 years, and down -910.07% over the past 5 years
All-Time High Comparison
VRDN annual cash from investing is currently -910.07% below its historical high of $28.23M set on
3-Year Low Comparison
VRDN annual cash from investing is at its 3-year low
Sector Comparison
VRDN annual cash from investing is higher than 11.11% of companies in Healthcare sector

Cash From Investing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRDN Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Investing-$228.65M-142.6%-207.8%-910.1%-10000.0%
Quarterly Cash From Investing$126.08M+248.9%+10000.0%
TTM Cash From Investing$238.94M+171.2%+2570.3%
Price$30.57+46.2%+11.3%+66.1%
Annual Cash From Operations-$232.32M-26.1%-325.6%-544.3%-3632.2%
Annual Cash From Financing$457.74M+102.8%+265.4%+10000.0%+7784.4%
Annual CAPEX$511.00K-43.1%+51.2%+508.3%+378.0%
Annual Free Cash Flow-$232.83M-25.8%-323.9%-544.2%-3577.2%
Annual Total Assets$742.40M+51.4%+264.4%+2353.3%+10000.0%

Cash From Investing Highs

VRDN Annual Cash From Investing Highs Comparison
PeriodHighDateCurrent
3Y-$94.25M-142.6%
5Y-$50.48MN/A-352.9%
All$28.23M-910.1%

Cash From Investing Lows

VRDN Annual Cash From Investing Lows Comparison
PeriodLowDateCurrent
3Y-$228.65Mat low
5Y-$228.65Mat low
All-$228.65Mat low

Cash From Investing History

YearValueChange
-$228.65M-142.6%
-$94.25M+18.1%
-$115.13M-55.0%
-$74.29M-47.2%
-$50.48M-278.8%
$28.23M+194.4%
YearValueChange
-$29.91M-2,992.4%
$1.03M>+9,900.0%
-$3,000.00+96.8%
-$95.00K+65.3%
-$274.00K-

FAQ

  • What is the current annual cash from investing of VRDN?

    As of today, VRDN annual cash from investing is -$228.65M

  • What is 1-year change in VRDN annual cash from investing?

    VRDN annual cash from investing is down -142.60% year-over-year

  • What is 3-year change in VRDN annual cash from investing?

    VRDN annual cash from investing is down -207.77% over the past 3 years

  • How far is VRDN annual cash from investing from its all-time high?

    VRDN annual cash from investing is currently -910.07% below its historical high of $28.23M set on December 31, 2019

  • How does VRDN annual cash from investing rank versus sector peers?

    VRDN annual cash from investing is higher than 11.11% of companies in Healthcare sector

  • When is VRDN next annual earnings release?

    The next annual earnings release for VRDN is on

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

Data Sources & References

  1. VRDN Official Website www.viridiantherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075025000020/0001590750-25-000020-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075025000004/0001590750-25-000004-index.htm
  4. VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
  5. VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn